Key result
This document is a journal masthead and does not contain clinical study results.
Why the study?
Does widespread laboratory testing for thrombophilia provide clinical benefit or cause harm?
Does widespread laboratory testing for thrombophilia provide clinical benefit or cause harm?
Excessive or inappropriate laboratory testing for thrombophilia is likely doing more harm than good, highlighting the need for scrutinized ordering practices.
No takes yet. Share an insight, caveat, or question.
Thrombophilia classifications may inform testing; leaves open standardized congenital vs acquired risk assessment in practice.
Favaloro et al. (2009) reported an editorial. This document is a journal masthead and does not contain clinical study results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: